ArticleFrontiers in oncology2022

Polo-like kinase-1, Aurora kinase A and WEE1 kinase are promising druggable targets in CML cells displaying BCR::ABL1-independent resistance to tyrosine kinase inhibitors.

Manuela Mancini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.